We are seeking to obtain feedback from the UMB community for topics to be covered in our ClinicalTrials.gov program webinar series.  We want to hear from everyone that interacts with the Program. FDAA 801. Regulation FDAA 801 specifies that the Responsible Party is accountable for the accuracy and completeness of the study registration. Non-compliance with FDAAA and ICMJE requirements can have serious consequences.